Italian Sarcoma Group

More than 140 experts from around the world came together last week to work toward improving the standard of care for chordoma via upcoming updated consensus guidelines -- a remarkable effort. Grateful to @alegronchi, @AOSpine & all who participated!

June 27, 2025 — 143 specialists from 17 countries and 11 disciplines convened at @INT_Milano to revise the international consensus on the management of localized primary #chordoma. An initiative by @ChordomaFDN , co-branded with @AOSpine. Toward updated, evidence-based guidelines

A comparison of the risk prediction models PERSARC and Sarculator in patients with localized soft tissue sarcoma of the extremities and trunk wall in @ESMO_Open. High degree of agreement, high-risk pts by either tool had improved outcomes with (N)A chemo. esmoopen.com/article/S2059-…

All’Istituto Nazionale dei Tumori di Milano una terrazza intitolata a Carlo Clerici medico prestigiatore amato dai bimbi. ilgiorno.it/milano/cronaca…

What a crew of global thought leaders! Thank you for your efforts.

🎗 July is #Sarcoma Awareness Month! At the Italian Sarcoma Group, we’re committed every day to advancing research, improving care and standing by patients and families. Together, we fight rare cancers. 💛 #SarcomaAwareness #SarcomaStrong #ISG #RareButResilient

Tumore della colonna vertebrale, speranze da un nuovo trattamento meno invasivo - Focus Tumore news - Ansa.it ansa.it/canale_salutee…

Il bando per la selezione di 3 felllow di chirurgia oncologica è fuori! Affrettatevi! fondazionesico.org/fellowship-in-…

🌟 We’re thrilled to announce that Dr. Alessandro Gronchi will deliver the prestigious @_CSSO Shibata Lecture at #CSF2025! A global leader in soft tissue sarcoma surgery, @alegronchi brings unparalleled expertise and insight to the CSF. Don't miss it ➡️ buff.ly/c7SY4kr

I’m deeply honored to give this lecture and can’t wait to come over! 😊

🎓Congratulations Joshua Bleicher on graduating from #surgonc fellowship! Dr Bleicher is now heading towards a new exciting surgical oncology practice 👏 ✨Bright new chapter ahead! @UofTSurgery @SocSurgOnc @_CSSO

💥 Recurrent retroperitoneal sarcomas: rare, aggressive, and tough to treat. 🔪 Live surgery 🧠 Expert case discussions 📚 Guideline updates 🏥 Focus on referral centers 📍June 18 | Campus Bio-Medico, Rome 🌍 Also streaming online! #SarcomaSurgery #RetroperitonealSarcoma

For the first time, we’ve set benchmark values for surgery in primary retroperitoneal liposarcoma (WDLPS/DDLPS). 15 expert centres. 22 key metrics. A new standard for measuring surgical quality. Presented at #CTOS2024. Great collaborative effort from @TARPSWG.

Fantastic work Fabio! Very well done! @TARPSWG @ctosociety @ItaSarcomaGroup @ESSOnews @SocSurgOnc @oncoteamsarcoma